| Q37622288 | "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment |
| Q36121867 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin differentially suppresses angiogenic responses in human placental vein and artery endothelial cells |
| Q60301465 | A peptide mimicking the binding sites of VEGF-A and VEGF-B inhibits VEGFR-1/-2 driven angiogenesis, tumor growth and metastasis |
| Q34333820 | A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1 |
| Q24559732 | A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters |
| Q96136180 | ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation |
| Q47277760 | Activated Ras induces a proangiogenic phenotype in primary endothelial cells |
| Q34635176 | Aflibercept in the treatment of metastatic colorectal cancer |
| Q46775274 | Altered VEGF-A and receptor mRNA expression profiles, and identification of VEGF144 in foetal rat calvaria cells, in coculture with microvascular endothelial cells |
| Q40549904 | An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. |
| Q73228269 | Angiogenesis in hematology: a field of active research |
| Q36230890 | Angiogenesis: update 2005. |
| Q44883177 | Anti-chemorepulsive effects of vascular endothelial growth factor and placental growth factor-2 in dorsal root ganglion neurons are mediated via neuropilin-1 and cyclooxygenase-derived prostanoid production |
| Q34974876 | Antiangiogenic agents targeting vascular endothelial growth factor and its receptors in clinical development |
| Q47649124 | Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway |
| Q34443661 | Autocrine VEGF signaling is required for vascular homeostasis |
| Q38011768 | Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer |
| Q47611649 | CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island |
| Q85015061 | Cancer of the corpus uteri |
| Q53322874 | Cancer of the corpus uteri. |
| Q89910525 | Central Role of Oxidative Stress in Age-Related Macular Degeneration: Evidence from a Review of the Molecular Mechanisms and Animal Models |
| Q58449597 | Characterization of a Bicyclic Peptide Neuropilin-1 (NP-1) Antagonist (EG3287) Reveals Importance of Vascular Endothelial Growth Factor Exon 8 for NP-1 Binding and Role of NP-1 in KDR Signaling |
| Q35949632 | Complexity in the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF)-receptors signaling |
| Q28579494 | Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferation |
| Q28575727 | Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway |
| Q36392576 | Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production. |
| Q33995228 | Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2 |
| Q56815794 | DARPP-32 and t-DARPP promote non-small cell lung cancer growth through regulation of IKKα-dependent cell migration |
| Q35884110 | DNA conjugated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis |
| Q40178858 | Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration |
| Q24302190 | Development of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding site |
| Q36844669 | Differential effects of cyclic and static stretch on coronary microvascular endothelial cell receptors and vasculogenic/angiogenic responses |
| Q35764454 | Differential expression of vascular endothelial growth factor (VEGF), endocrine gland derived-VEGF, and VEGF receptors in human placentas from normal and preeclamptic pregnancies |
| Q34365504 | Differential regulation of orphan nuclear receptor TR3 transcript variants by novel vascular growth factor signaling pathways |
| Q57116380 | Dihydroartemisinin enhances VEGFR1 expression through up-regulation of ETS-1 transcription factor |
| Q24312658 | Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK, AKT, and JNK pathways |
| Q41891694 | Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting |
| Q51642790 | Effect of oxygen and glucose deprivation on VEGF and its receptors in microvascular endothelial cells co-cultured with mast cells. |
| Q43189547 | Embryonic vasculogenesis and hematopoietic specification |
| Q38065241 | Emerging VEGF-receptor inhibitors for colorectal cancer |
| Q35974766 | Exendin-4 protects HUVECs from t-BHP-induced apoptosis via PI3K/Akt-Bcl-2-caspase-3 signaling |
| Q47395346 | Expression and Function of the Vascular Endothelial Growth Factor Receptor FLT-1 in Human Eosinophils |
| Q33769685 | Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease |
| Q34439734 | Fast rearrangement of the neuronal growth cone's actin cytoskeleton following VEGF stimulation |
| Q37231437 | Fine-tuning the angiogenic response to vascular endothelial growth factor |
| Q40765930 | Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1. |
| Q34717950 | Focal adhesion kinase controls cellular levels of p27/Kip1 and p21/Cip1 through Skp2-dependent and -independent mechanisms. |
| Q50123361 | From biology to therapy: Improvements of therapeutic options in Lung cancer. |
| Q93185552 | Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer |
| Q35937557 | Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia |
| Q36021580 | Genetic and hypoxic regulation of angiogenesis in gliomas |
| Q35568152 | Growing and shaping the vascular tree: multiple roles for VEGF |
| Q28290402 | Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells |
| Q28180577 | Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo |
| Q83979034 | Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin |
| Q36321428 | Inhibition of endothelial cell migration by thrombospondin-1 type-1 repeats is mediated by beta1 integrins |
| Q56892691 | Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine |
| Q51131994 | Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. |
| Q24632703 | Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer |
| Q38008362 | Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following Transplantation |
| Q43740142 | LDL attenuates VEGF-induced angiogenesis via mechanisms involving VEGFR2 internalization and degradation following endosome-trans-Golgi network trafficking. |
| Q26775043 | Lenvatinib: Role in thyroid cancer and other solid tumors |
| Q34331369 | Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A |
| Q24302083 | Magic roundabout, a tumor endothelial marker: expression and signaling |
| Q52767617 | Matrix Stiffness Enhances VEGFR-2 Internalization, Signaling, and Proliferation in Endothelial Cells. |
| Q36475841 | MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling. |
| Q47952830 | Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells |
| Q34566028 | Molecular and functional diversity of vascular endothelial growth factors |
| Q36010234 | NHERF-2 maintains endothelial homeostasis |
| Q47666008 | Neocortical developmental analysis of vasculature and their growth factors offer new insight into fragile X syndrome abnormalities. |
| Q38349883 | Neuropilin-1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor-dependent Endothelial Cell Migration |
| Q34847842 | Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin β4 |
| Q36228417 | Orphan nuclear receptor TR3/Nur77 regulates VEGF-A-induced angiogenesis through its transcriptional activity |
| Q54682241 | Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. |
| Q64379300 | PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects |
| Q37986561 | Patients with metastatic breast cancer using bevacizumab as a treatment: is there still a role for it? |
| Q28285900 | Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1 |
| Q43867569 | Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers |
| Q34292149 | Placental growth factor induces FosB and c-Fos gene expression via Flt-1 receptors |
| Q38647883 | Precise scheduling of chemotherapy primes VEGF-producing tumors for successful systemic oncolytic virotherapy |
| Q36281111 | Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets |
| Q44445189 | Regulation of 1-alpha, 25-dihydroxyvitamin D3 on interleukin-6 and interleukin-8 induced by sulfur mustard (HD) on human skin cells |
| Q35757924 | Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis |
| Q40669797 | Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line |
| Q34031787 | Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes |
| Q40618771 | Role of Insulin Receptor Substrates and Protein Kinase C-ζ in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells |
| Q24304277 | Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 |
| Q34239172 | Selective assembly of DNA-conjugated single-walled carbon nanotubes from the vascular secretome |
| Q37362646 | Single-molecule detection of H₂O₂ mediating angiogenic redox signaling on fluorescent single-walled carbon nanotube array |
| Q44643921 | Snake Venom Vascular Endothelial Growth Factors (VEGFs) Exhibit Potent Activity through Their Specific Recognition of KDR (VEGF Receptor 2) |
| Q55008337 | Targeting VEGF/VEGFR to Modulate Antitumor Immunity. |
| Q50216101 | The Role of Maternal Gestational Diabetes in Inducing Fetal Endothelial Dysfunction |
| Q54321577 | The corpora lutea proangiogenic state of VEGF system components is turned to antiangiogenic at the later phase of the oestrous cycle in cows. |
| Q35083393 | The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection |
| Q24538981 | The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1 |
| Q35116734 | The merits of vascular targeting for gynecologic malignancies |
| Q38462638 | The role of anti-angiogenesis in non-small-cell lung cancer: an update |
| Q36907325 | The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion |
| Q35098106 | The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation |
| Q36682884 | The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3/Nur77 and subsequently truncate it through thrombospondin-1. |
| Q35418973 | Therapeutic advances in women's cancers |
| Q41775575 | Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells |
| Q28578381 | VEGF links hippocampal activity with neurogenesis, learning and memory |
| Q29617256 | VEGF receptor signalling - in control of vascular function |
| Q90698963 | VEGF receptor-1 modulates amyloid β 1-42 oligomer-induced senescence in brain endothelial cells |
| Q44043571 | VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism |
| Q53305892 | VEGF stimulates PKD-mediated CREB-dependent orphan nuclear receptor Nurr1 expression: role in VEGF-induced angiogenesis. |
| Q50125265 | VEGF, FGF-2 and TGFβ expression in the normal and regenerating epidermis of geckos: implications for epidermal homeostasis and wound healing in reptiles |
| Q34480730 | VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling |
| Q35296110 | VEGF-receptor signal transduction |
| Q36949564 | VEGF: an essential mediator of both angiogenesis and endochondral ossification |
| Q34333828 | VEGFR-1 and VEGFR-2: two non-identical twins with a unique physiognomy |
| Q35585704 | VEGFR-1 overexpression identifies a small subgroup of aggressive prostate cancers in patients treated by prostatectomy |
| Q37358053 | Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways |
| Q24297590 | Vascular endothelial growth factor (VEGF)-D and VEGF-A differentially regulate KDR-mediated signaling and biological function in vascular endothelial cells |
| Q35919917 | Vascular endothelial growth factor and the nervous system. |
| Q35939630 | Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer. |
| Q24305184 | Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines |
| Q35049227 | Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials. |
| Q36371903 | Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis |
| Q36672598 | Yeast-derived beta-glucan augments the therapeutic efficacy mediated by anti-vascular endothelial growth factor monoclonal antibody in human carcinoma xenograft models |